Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | FABP4 | P15090 | 4/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL224062 | 0.84 | S1PR3 (0.32) | CYP26B1S1PR3ALDH1A1TBXA2RPKM | |
| SCHEMBL31657046 | 0.83 | S1PR3 (0.32) | S1PR3 | |
| SCHEMBL10111553 | 0.80 | HDAC11 (0.41) | ALDH1A1FABP4MAPK1TDP1 | |
| SCHEMBL16360447 | 0.78 | S1PR3 (0.35) | CYP26B1S1PR3ALDH1A1TDP1 | |
| SCHEMBL47248 | 0.78 | MEN1 (0.39) | CYP26B1S1PR3ALDH1A1TBXA2RPKM | |
| SCHEMBL31278367 | 0.77 | FOLH1 (0.43) | ALDH1A1TBXA2RPKMFABP4MAPK1 | |
| Bromide SCHEMBL6537380 | 0.77 | MEN1 (0.38) | CYP26B1S1PR3ALDH1A1TBXA2RPKM | |
| SCHEMBL13998245 | 0.76 | MEN1 (0.39) | CYP26B1ALDH1A1TBXA2RPKMFABP4 | |
| SCHEMBL251206 | 0.75 | MEN1 (0.39) | CYP26B1ALDH1A1TBXA2RPKMFABP4 | |
| SCHEMBL11912398 | 0.75 | ALDH1A1 (0.33) | CYP26B1S1PR3ALDH1A1TBXA2RPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120052506-A1 | CYANINE DYES | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| EP-2223086-A1 | FLUORESCENT COMPOUNDS | Biotium Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009078970-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. (US) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052506-A1 | CYANINE DYES | ABCG2, IK, ACR | CYP26B1 2082/4885S1PR3 3432/4885ALDH1A1 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.